1034 related articles for article (PubMed ID: 22313314)
1. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
[TBL] [Abstract][Full Text] [Related]
3. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
4. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of atrial arrhythmias in a primary prevention ICD population.
van Gelder IC; Phan HM; Wilkoff BL; Brown ML; Rogers T; Peterson BJ; Birgersdotter-Green UM
Pacing Clin Electrophysiol; 2011 Sep; 34(9):1070-9. PubMed ID: 21605131
[TBL] [Abstract][Full Text] [Related]
6. Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks.
Hreybe H; Ezzeddine R; Barrington W; Bazaz R; Jain S; Ngwu O; Saba S
Am J Cardiol; 2006 Feb; 97(4):544-6. PubMed ID: 16461053
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M
Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
[TBL] [Abstract][Full Text] [Related]
9. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
[TBL] [Abstract][Full Text] [Related]
10. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
[TBL] [Abstract][Full Text] [Related]
11. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
13. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
Spencker S; Coban N; Koch L; Schirdewan A; Müller D
Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
[TBL] [Abstract][Full Text] [Related]
16. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.
Olde Nordkamp LR; Brouwer TF; Barr C; Theuns DA; Boersma LV; Johansen JB; Neuzil P; Wilde AA; Carter N; Husby M; Lambiase PD; Knops RE
Int J Cardiol; 2015 Sep; 195():126-33. PubMed ID: 26026928
[TBL] [Abstract][Full Text] [Related]
17. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH;
Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.
Smit MD; Van Dessel PF; Rienstra M; Nieuwland W; Wiesfeld AC; Tan ES; Anthonio RL; Van Veldhuisen DJ; Van Gelder IC
Europace; 2006 Aug; 8(8):566-72. PubMed ID: 16864611
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
